Enveric Biosciences, Inc. (ENVB): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

Stock splits: 1-for-25, first reflected in a filing dated 2020-03-25; 1-for-12, first reflected in a filing dated 2025-11-14. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

334.7K
Year ended 2025-12-31
14.98M2015-12-31: 11.10M2016-12-31: 13.07M2017-12-31: 14.98M2018-12-31: 951.6K2019-12-31: 2.13M2022-12-31: 1.45M2023-12-31: 143.9K2024-12-31: 41.9K2025-12-31: 334.7K334.7K
2015-12-31 Weighted Average Diluted Shares (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-31334.7K+698.7%2026-03-27, From 2025-01-01
2024-12-3141.9Kn/c2026-03-27, From 2024-01-01
2023-12-31143.9Kn/c2025-03-28, From 2023-01-01
2022-12-311.45Mn/c2024-03-26, From 2022-01-01
No annual figure between 2019-12-31 and 2022-12-31.
2019-12-312.13M+123.7%2020-08-12, From 2019-01-01
2018-12-31951.6Kn/c2020-08-12, From 2018-01-01
2017-12-3114.98M+14.6%2019-03-26, From 2017-01-01
2016-12-3113.07M+17.7%2018-04-02, From 2016-01-01
2015-12-3111.10Mn/a2017-04-04, From 2015-01-01